Professional Documents
Culture Documents
Erythropoiesis in CKD
Hemoglobin
64.4 kd tetramer 2 pairs of globin polypeptide chains - One pair alpha chains - One pair of non-alpha chains non Heme group single protoporphyrin IX bound to ferrous (Fe2+) ion linked covalently to each globin chain - If iron is oxidized [ferric state (Fe3+)] metHb Heme iron is linked covalently to histidine Oxygenation and deoxygenation Hb conformational
Ganzonis formula
Total Fe deficit (mg) = [Wt (kg) x (14 - actual Hb) x 0.24] + 500 (iron depot) - Blood volume 70 ml/kg of BW ~7% of body weight - Fe content of Hb 0.34% - Factor 0.24 = 0.0034 x 0.07 x 1000 (g to mg).
70 kg; Hb 9 g/dL ~ deficit of 1400 mg. Underestimation of iron depot in males - ~ 700-900 mg. 700Muoz M, et al. World J Gastroenterol 2009; 15(37): 4666-4674 Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr. 1970;100: 301303.
Parenteral Iron
http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022180lbl.pdf
Difficult beginnings
Self limited arthralgias and myalgias ~ 50% - Only 1 in 87 patients had nonfatal anaphylaxis - Decreased with methylprednisolone (125 mg) before and after infusion (1998) - No relationship with infusion rate - Lack of efficacy of ASA and diphenhydramine Single case report in Lancet (1983) of meningismus - Patient with myalgia/arthralgia syndrome Oral iron - inexpensive and effective if tolerated - decreased interest in parenteral iron.
Iron in ESRD
Eschbach (1987) 1g IV Fe dextran in dialysis patients failing to respond to EPO (standard dose of 50 U/kg 3 x wk) despite Ferritin > 500 ng/ ml. Fishbane IV Fe: - Decreased suboptimal response to EPO: 3040% to < 10% 30 - dosing and duration of EPO - Poor compliance and absorption avoid PO Fe - IV Fe 1g rapid improvement of erythropoiesis and replenishment of depleted stores. Administered over 10 doses. Serious AE ~ 0.7% ~ 0.3% - acute chest and back pain without BP, RR, HR, wheezing, stridor, or periorbital edema Self limited reactions.
Auerbach M. Am J Hematol. 2008; 83: 580588
Iron in ESRD
NKF-KDOQI - IV iron in preference to p.o. iron - Serum ferritin >100 ng/ mL - Continue Fe as long as ferritin <800 ng/mL. - Halt iron therapy if the Tsat > 50% - IV iron can be administered: LMWD total infusion dose or repeated doses Ferric gluconate or iron sucrose repeated doses
Identify patients at risk of receiving perioperative transfusions - patients red blood cell mass - transfusion trigger - expected blood loss Check Hb and iron status (serum iron, serum ferritin, transferrin saturation, and C-reactive protein) ~ 30 days before surgery. CFor patients > 60 yr old, vitamin B12 and folic acid should also be measured. Iron replacement per Ganzonis formula. Postoperatively 150 mg of i.v. iron per g/dl of Hb drop should be added to compensate iron loss due to perioperative bleeding.
Preoperative Fe administration in non-anemic patients: non- Ferritin < 100 ng/ml - Ferritin 100300 ng ml and Tsat < 20% 100 - Surgery with EBL > 1500 ml (Hb drop ~f 35 g/dl) 3 IV Fe should be avoided in: - Ferritin > 300 ng/ml and Tsat > 50%. - Acute infection.
Bieber EJ. OBG Management. 2010;22(2):28-38. Silverstein SB. Am J Hematol. 2004; 76:7478.